Skip to content

Enovis ENOV Non-Controlling Interests

Non-Controlling Interests at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$8.2M-5.7%
ESAB logo
ESABESAB
$44.88M+10.4%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$786.7M+8.9%
Medtronic logo
MedtronicMDT
$609M+163%
Baxter International logo
Baxter InternationalBAX
-$27M0.0%
AdaptHealth logo
AdaptHealthAHCO
$7.41M+22.3%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's non-controlling interests?
Enovis (ENOV) reported non-controlling interests of $2.57M in Q1 2026.
How has Enovis's non-controlling interests changed year-over-year?
Enovis's non-controlling interests increased by 4.9% year-over-year, from $2.45M to $2.57M.
What is the long-term trend for Enovis's non-controlling interests?
Over 5 years (2020 to 2025), Enovis's non-controlling interests has grown at a -44.9% compound annual growth rate (CAGR), from $44.49M to $2.26M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.